This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: Massachusetts Institute of Technology, The Brigham and Women's Hospital, Inc., Columbia University. Active years: 2019-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:



Years Active: 2019-2020
Title: Innovations by Xiaoyang Xu in Nanoparticle Technology
Introduction
Xiaoyang Xu is a prominent inventor based in Cambridge, MA, known for his groundbreaking work in the field of nanoparticle technology. He holds 2 patents that focus on innovative methods for drug delivery and therapeutic applications. His research has significant implications for medical treatments and diagnostics.
Latest Patents
Xu's latest patents include "Cationic nanoparticles for co-delivery of nucleic acids and therapeutic agents." This invention involves nanoparticles that contain an aqueous core with nucleic acids, such as siRNA, and a shell made of hydrophobic cationic materials. These materials create a non-polar polymer matrix that enhances drug loading and protects siRNA molecules, while also controlling drug release. The hydrophilic portion of the amphiphilic material forms a corona around the particle, which prolongs circulation in the bloodstream and reduces uptake by the reticuloendothelial system.
Another significant patent is "Targeted polymeric inflammation-resolving nanoparticles." This invention features sub-100 micron multimodal nanoparticles that consist of four main components: a targeting element, a diagnostic agent, a stealth layer, and a biodegradable polymeric material. These nanoparticles are designed to selectively bind to specific cells or tissues, allowing for effective delivery of therapeutics while evading the immune system. They are particularly useful in targeting inflammation associated with various diseases and treatments.
Career Highlights
Xiaoyang Xu has made substantial contributions to the field of biomedical engineering through his work at notable institutions. He has been affiliated with The Brigham and Women's Hospital, Inc. and the Massachusetts Institute of Technology, where he has collaborated on various research projects aimed at advancing nanoparticle technology.
Collaborations
Throughout his career, Xu has worked alongside esteemed colleagues, including Xueqing Zhang and Omid C Farokhzad. Their collaborative efforts have furthered the development of innovative solutions in drug delivery systems.
Conclusion
Xiaoyang Xu's contributions to nanoparticle technology have paved the way for advancements in medical treatments and diagnostics. His innovative patents reflect a commitment to improving healthcare through scientific research and collaboration.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile